Neuroscientific Biopharmaceuticals Ltd. Financial Overview
Neuroscientific Biopharmaceuticals Ltd.'s market cap is currently AU$33.26M. The company's EPS TTM is AU$-0.01; its P/E ratio is -7.94; Neuroscientific Biopharmaceuticals Ltd. is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
